drugset / Trial / NCT03323697
Chinese Herb for the Treatment of Depression and Anxiety Disorders
Phase 1/2
Unknown
60 enrolled
Mazra Mental Health Center
The Academic College of Tel-Aviv Yaffo · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Anxiety and depression are currently among the ten most important public health concerns, and in recent years, have reached epidemic proportions. Anxiety is recognized as the main risk factor for many diseases including cardiovascular, metabolic and neuropsychiatric disorders. Current anxiolytic medications have a relatively low success rate (\~50%) and are associated with many deleterious side-effects. The investigators aim to investigate the efficacy, safety, and tolerability of a novel herbal treatment on anxiety and depression symptoms in a 6-week double-blind randomized trial.
Timeline
- Start
- 2017-08-28
- Primary completion
- 2018-09-01
- Completion
- 2018-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Escitalopram | Small molecule | 10 mg | — |